Myocardial Infarction News and Research

RSS

Study finds lower cancer risk with alcohol abstinence and rehabilitation

A new study conducted by the Centre for Addiction and Mental Health (CAMH), Bordeaux University Hospital, France, and the World Health Organization (WHO) has found that individuals with alcohol dependence who undergo rehabilitation or maintain abstinence experience significantly lower risks of developing alcohol-associated cancers.

26 Jun 2024

Plant-based meat substitutes show promise for heart health

Even though there is substantial variability in the contents and nutritional profiles of plant-based meat alternatives (PBMAs), the nutritional profiles tend to reflect a heart-healthy dietary pattern.

26 Jun 2024

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

The FLOW trial demonstrated that semaglutide significantly improves kidney and cardiovascular outcomes in people with chronic kidney disease and type 2 diabetes, irrespective of SGLT2 inhibitor use.

25 Jun 2024

Study reveals high rates of aspirin use for CVD prevention among older adults

A survey representing about 150 million adults annually suggests that aspirin use for primary prevention of cardiovascular disease (CVD) remains prevalent among older adults, contrary to recommendations from the American College of Cardiology and the American Heart Association.

24 Jun 2024

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA).

22 Jun 2024

Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond

A recent review in Diabetes Care evaluates the efficacy and safety of GLP-1 receptor agonists for type 2 diabetes and obesity, exploring their potential for new medical indications.

18 Jun 2024

Waist-to-height ratio surpasses conventional metrics in predicting cardiovascular disease risk

Research shows waist-to-height ratio (WHtR) outperforms body fat percentage (BF%) and other central obesity measures in predicting ischemic cardiovascular disease (CVD) risk.

12 Jun 2024

Study reveals a key step to help the heart regenerate after myocardial infarction

A new study by investigators at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham (MGB) healthcare system, reveals an important step to help the human heart regenerate after myocardial infarction (MI).

10 Jun 2024

Vigorous exercise linked to lower dementia risk in hypertensive individuals

The effect of vigorous physical activity (VPA) on the risk of incident mild cognitive impairment (MCI) and probable dementia.

10 Jun 2024

Novel insights into the underlying, contributing, and direct causes of death in Australia

Coronary heart disease (CHD) was involved in 1 in 5 deaths in 2022 when using all of the information included on the medical death certificate, according to a new Australian Institute of Health and Welfare (AIHW) release revealing what Australians are most likely to die from.

8 Jun 2024

Moderate choline intake lowers heart disease risk

A recent study from BMC Public Health found that moderate dietary choline intake is associated with a reduced risk of atherosclerotic cardiovascular disease (ASCVD) among US adults.

4 Jun 2024

Studies underscore the relationship between narcolepsy and cardiovascular disease

Two new studies to be presented at the SLEEP 2024 annual meeting show that narcolepsy is an independent risk factor for cardiovascular disease and adverse cardiac events.

4 Jun 2024

Coronary arterial inflammation linked to high cardiac event risk even without CAD

Researchers in The Lancet highlight coronary arterial inflammation's role in increasing major adverse cardiac events and cardiovascular deaths, irrespective of coronary artery disease presence.

3 Jun 2024

Garlic proves potent in reducing blood sugar and cholesterol, study reveals

Study confirms garlic's significant benefits in lowering blood glucose and lipid levels, offering a natural remedy for metabolic disorders.

2 Jun 2024

Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings

Semaglutide and its effects on glycemic control, body weight (BW), and tolerability in routine clinical practice.

28 May 2024

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

Researchers found that semaglutide treatment for weight loss in non-diabetic, obese men is associated with an increased risk of erectile dysfunction and testosterone deficiency.

26 May 2024

Are step counts as effective as time-based exercise in boosting health?

Monitoring physical activity with either step counts or time spent exercising shows similar benefits in reducing cardiovascular disease and all-cause mortality among women in their 60s. Both methods support health guidelines and personal preference.

23 May 2024

Study finds microplastics in blood clots, linking them to higher risk of heart attacks and strokes

A study in EBioMedicine reveals significant microplastic concentrations in thrombi from major blood vessels, linking microplastic levels to increased risk and severity of thrombotic events.

22 May 2024

Eating more potatoes may lower your risk of heart disease and early death, study finds

A Norwegian study found that higher potato consumption moderately reduces the risk of all-cause and cardiovascular disease mortality in adults.

21 May 2024

Are fish oil supplements associated with cardiovascular disease?

The effects of using fish oil supplements on the clinical progression of cardiovascular disease.